New radioactive drug aims to shrink hard-to-treat prostate cancer
Disease control
Recruiting now
This early study tests a new drug called 3D1015 in men with a type of advanced prostate cancer that no longer responds to hormone therapy. The drug delivers radiation directly to cancer cells. The main goals are to check safety and find the best dose. About 8 men will take part.
Phase: PHASE1 • Sponsor: Chunjing Yu • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC